MoreTrials

MoreTrials: A public campaign to make it much easier to do randomised trials

You are here: Home / Fundamental problems with ICH-GCP Post / Fundamental problems with ICH-GCP: #5 – part 2 – Hiding behind complexity

Sep 18 2016

Fundamental problems with ICH-GCP: #5 – part 2 – Hiding behind complexity

image

I started writing this piece a few weeks back on holiday in the Algarve. It’s a follow on to the last piece on mindlessly following a recipe rather than thinking what matters when doing a trial. This time it looks at the value of simplicity.

I went for a quick run this morning before it got too hot. When I got back to our villa I jumped straight in the shower. Ten minutes later I was sitting down with a coffee chatting with my wife about what we might do today.

What the hell does this have to do with randomised trials I guess you might well be thinking?

In a word, simplicity. The shower knobs above have red for hot and blue for cold. Simple.

Now compare this with most modern hotels. A rule of thumb is the fancier the place the more unfathomable the controls. I’ve had ice cold showers, boiling hot ones, ones that required two calls down to reception and even no shower at all.

Thinking about trials, the trials that had a lasting impact, the ones that made a real difference. These weren’t the ones with really complex designs, with mountains of data collection, no, they answered one important question, and answered that question really reliably using a simple design. As discussed last time, it might be simple, but it’s deceptively difficult to do.

Much easier to follow instructions, instructions, like ICH-GCP.

Left to their own devices any system gets more complex because we keep adding “important” new stuff without taking anything else away. That’s exactly what ICH did when they updated ICH-GCP.

To avoid this, you have to make a deliberate choice to value simplicity and that’s hard. Edward de Bono summed it up in his book, “Simplicity”:

012

“As the world around grows even more complex, simplicity is becoming a key value. Left to themselves things grow even more complex rather than more simple. Simplicity has to be a choice, an effort and a design. A few people really hate simplicity – most people value it very highly but find it difficult to achieve.”

He wrote that back in 1998.

What then happens when we don’t make simplicity a priority is that we end up with trials based upon these instructions that are so complex that, at best, at the end of the trial give answers that leave you wondering, “so what”, or, from what I see from the ethics committee, don’t get finished, starting with a loud fanfare and then getting quietly abandoned.

Nobody ever gets punished for not completing a trial, in fact, we reward trialists for being responsible for multiple trials and nobody bothers to check whether or not they finish what they started. This matters because the finite resource at stake is public trust. Talk to trial participants who won’t most likely take part in another trial and the reason you’ll probably hear back will be something along the lines of,  “I took part in a trial but the company decided to cancel it before the end and nobody bothered to tell us.”

Somebody told me that this story might not be true, but it illustrates the value of simplicity well. Fisher Space PenDuring the Cold War astronauts needed a writing tool that worked in zero gravity. The US developed a brand new nitrogen filled pen, that you can still buy, but the Soviets lacking the resources, identified the value concept of “find something that writes upside down.” From this concept they gave their cosmonauts a much cheaper alternative to write things down in space, a pencil. Simple.

Here’s some simple logic as a response to complexity. I was at a training event a few months back for ethics committee members. The discussion was around the complexity, time and cost that it would take to do a simple randomised comparison of two standard treatments, if I recall rightly, it was comparing donated breast-milk with formula milk in women who were unable to breast feed their own newborn child. We went around in circles about all the hurdles the trialists would need to jump through, before a fellow committee chair came up with the neat solution along the lines of;

“Well, you don’t need to do a trial, just collect enough routine data, real-world data, in this particular group of women.”

So simple a solution, but so wrong of course.

Print Friendly

Written by tim sprosen · Categorized: Fundamental problems with ICH-GCP Post

Search Form

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

A public campaign for more, better, randomised trials

Pages

  • The Problem
    • ICH
    • ICH-GCP guideline
    • Response from EMA/ICH
    • Stories to Highlight the Problems
  • The Solution
    • Developing the New-GCP
    • The Plan
  • News
  • The unique value of randomised trials
    • Illustration
    • The wider context
    • CTTI: Making things better
    • Stories of Trials That Matter
  • Have your say
  • Supporters
    • AllTrials
  • Join us
  • Contact us

Join

Search Form

  • 
  • 

© 2016 Moretrials.net · Rainmaker Platform